Alpa Laboratories Approves Unaudited Financial Results for Quarter Ending June 30, 2026
Alpa Laboratories Limited (the Company) announced that its Board of Directors had approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended on June 30, 2026. The board also approved the notice for the company's 38th Annual General Meeting.The board meeting concerning these matters was held at 3:00 PM and concluded at 8:00 PM.
The Unaudited Financial Results provide a snapshot of the Company’s performance across various periods, detailed in both standalone and consolidated segments.
Consolidated Financial Performance
The Consolidated Statement of Profit and Loss for the quarter ending June 30, 2026, reflected specific operational metrics:| Metric | Qtr Ended Jun-26 (Unaudited) | Qtr Ended Mar-26 (Audited) | Qtr Ended Jun-25 (Unaudited) | Year Ended Mar-26 (Audited) |
|---|---|---|---|---|
| Revenue from Operations | 2,393.05 lacs | 3,139.56 lacs | 1,911.07 lacs | 10,580.96 lacs |
| Total Income from Operations | 2,975.98 lacs | 3,121.18 lacs | 3,106.85 lacs | 12,153.02 lacs |
| Total Expenses | 2,872.14 lacs | 2,816.74 lacs | 1,929.26 lacs | 10,488.97 lacs |
| Profit/(Loss) for the Period | 103.84 lacs | 135.70 lacs | 1,177.59 lacs | 495.31 lacs |
Standalone Financial Results
The Unaudited Standalone Financial Results similarly detailed operational performance across all periods:| Metric | Qtr Ended Jun-26 (Unaudited) | Qtr Ended Mar-26 (Audited) | Qtr Ended Jun-25 (Unaudited) | Year Ended Mar-26 (Audited) |
|---|---|---|---|---|
| Revenue from Operations | 2,393.05 lacs | 3,139.56 lacs | 1,911.07 lacs | 10,580.96 lacs |
| Total Income from Operations | 2,975.98 lacs | 3,121.18 lacs | 3,106.85 lacs | 12,153.02 lacs |
| Total Expenses | 2,872.14 lacs | 2,816.74 lacs | 1,929.26 lacs | 10,488.97 lacs |
| Profit/(Loss) for the Period | 103.84 lacs | 135.70 lacs | 1,177.59 lacs | 495.31 lacs |
The Company operates in the single segment of Drugs and Chemicals. The financial statements were prepared in accordance with the Companies (Indian Accounting Standards) Rules, 2015 (Ind AS).
ALPA Stock Price Movement
Alpa Laboratories Limited shares shed 1.89% on Thursday, settling at ₹65.85 after a full-day decline. The stock traded 30,275 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.